PANNA Study

PANNA Study

logo-panna-rgbPENTA provides financial support for the PANNA network of 17 centres across 7 European countries collecting pharmacokinetic data in HIV-positive pregnant women, led by David Burger at the Radboud University Nijmegen Medical Centre in the Netherlands.

Right now the network focuses on collecting much needed pharmacokinetic data on newly developed antiretroviral drugs during pregnancy in European populations, but could also collect these data for other antiviral compounds such as those for use against hepatitis C.

Additional support for PANNA is provided by NEAT, Merck, BMS, Janssen and CTN. Please find more about the network and various related studies here